[1] According to the researchers TGF-beta1 induction of angiogenesis requires a rapid and transient apoptotic effect mediated by VEGF/VEGFR2. AHK-Cu, by enhancing levels of the Vascular Endothelial Growth Factor, may possibly activate fibroblasts and endothelial cells
The same independent HPLC and Mass Spectrometry methods used for peptides verify its purity and identity, but the underlying chemistry is small-molecule organic synthesis
Systemic administration affects widespread pain rather than localized issues
All information presented here is neutral, factual, and written to support scientific discussion rather than clinical, therapeutic, or diagnostic application
Currently, BPC-157 pills are not approved by the FDA for medical use, including therapeutic applications and clinical treatments
BPC-157 Injection Resolved Bladder Pain Symptoms in 10 of 12 Women: A Pilot Study. Alternative therapies in health and medicine.Study breakdown PubMed 6RPEP-01187Sikiric, P et al